SMMT SUMMIT THERAPEUTICS INC US FDA Inspections 8-K Filing 2023 - Other Special Situation Summit Therapeutics announced the enrollment and treatment of the first US-based patient in the Phase III HARMONi study.Get access to all SEC 8-K filings of the SUMMIT THERAPEUTICS INC